High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial—Correction

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.294.24.3092
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors

Unknown

Publisher

American Medical Association (AMA)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy